Eureka: A Turkish biomedical company seeks partner to develop a multichannel Quantitative Real-Time Polymerase Chain Reaction (QRT-PCR) device.
Turkish biomedical company is looking for partners to apply to Eurostars to further develop a multichannel Quantitative Real-Time Polymerase Chain Reaction (QRT-PCR) device. By diagnosing infectious diseases using the QRT-PCR device, the type of pathogen, and the level of infection are precisely determined. The main objective of the cooperation is to develop a versatile and low-cost multichannel QRT-PCR device. The partnership is a research cooperation agreement to participate in Eurostars.